1 |
Creative Commons |
Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations |
Professor Astrid Iversen discusses research published in Nature, using historic genome data to investigate the emergence of genetic risk for multiple sclerosis in Northern Europe. |
Astrid Iversen, Paul Klenerman |
06 Nov 2024 |
2 |
|
Dr Alex Mentzer |
Georgina Ferry interviews Alex Mentzer, NIHR Academic Clinical Lecturer, 25 January 2023. |
Alex Mentzer, Georgina Ferry |
12 Jun 2023 |
3 |
Creative Commons |
Series 2 Episode 7 - Why research regulation falls short in genomic medicine |
As a society, we tend to focus a lot on risk and try to control it through regulation - but how well does that work for ensuring ethical practice in genomics? We talk to Dr Kate Lyle about her research on this topic. |
Rachel Horton, Gabrielle Samuel, Kate Lyle |
02 May 2023 |
4 |
|
Series 2 Episode 6 - Diversifying genomics |
What are the ethical challenges with diversifying genomic data? We talk to Faranak Hardcastle about her work exploring this. |
Rachel Horton, Gabrielle Samuel, Faranak Hardcastle |
07 Mar 2023 |
5 |
|
Series 2 Episode 4 - Newborn genome screening |
What sort of findings might we get from newborn genome screening? What might this mean for the NHS? Rachel Horton talks to Gabby Samuel and Lisa Ballard. |
Rachel Horton, Gabrielle Samuel, Lisa Ballard |
20 Oct 2022 |
6 |
|
Series 2 Episode 3 - Sharing genetic results within families |
Who does a genetic result belong to? What might help people to share genetic information with their relatives? We talk to Lisa Ballard and Anneke Lucassen. |
Rachel Horton, Gabrielle Samuel, Lisa Ballard, Anneke Lucassen |
16 Aug 2022 |
7 |
Creative Commons |
Series 2 Episode 2 - Why context matters in genetic testing |
How can the same genetic finding can mean different things in different people? What does this mean for 'personalising' genetic results? Anneke Lucassen talks to us about this issue. |
Rachel Horton, Gabrielle Samuel, Anneke Lucassen |
18 Jul 2022 |
8 |
|
Gut Instinct Ep. 4 - C. difficile therapeutics, liver spatial genomics, and paediatric hepatitis |
What a week! We discuss some cracking papers, including a new microbiome therapeutic for C. diff, spatial transcriptomics in the liver, and the recent epidemic of paediatric hepatitis. |
Michael FitzPatrick and Tamsin Cargill |
18 May 2022 |
9 |
Creative Commons |
Genomics and global health |
Professor Olivo Miotto from our MORU programme in Bangkok, Thailand, tells us how genomics can help us improve global health |
Olivo Miotto |
12 Jul 2019 |
10 |
|
You know nothing about dogs, pigs or chickens! |
In Professor Greger Larson's short talk he unearths some new truths about the domestication of some familiar animal friends. |
Greger Larson |
25 Apr 2017 |
11 |
|
Sociogenomics – when nature meets nurture |
In this short talk, Professor Melinda Mills introduces her work on the role of gene and gene-environment interaction on reproductive health |
Melinda Mills |
12 Apr 2017 |
12 |
|
Genomic revolution and its impact on prostate cancer care |
Professor Ash Tewari talks about the genomics of prostate cancer and the implications for managing high risk disease. |
Ash Tewari |
05 Jan 2016 |
13 |
|
'Explosions' part 3 - Health and Big Data |
Professor Gil McVean explains what Big Data is and how it can be used to better understand and treat complex conditions, such as heart disease and dementia. |
Gil McVean |
30 Mar 2015 |
14 |
|
Patent Policy in Genomics and Human Genetics: Epistemic Communities, Courts and the Democratic Shaping of Patent Law |
Professor Dr Ingrid Schneider gives a talk for the FLJS seminar series. |
Ingrid Schneider |
17 Feb 2015 |
15 |
Creative Commons |
Oxford at Said: A human genome in minutes and what it will mean to you |
Oxford Nanopore is a British company, spun out of the University of Oxford in 2005 and founded on the science of Prof Hagan Bayley. It is developing new technology that has the potential to improve greatly the speed and cost of DNA sequencing. |
Hagan Bayley |
25 Mar 2013 |
16 |
Creative Commons |
Oxford at Said: A human genome in minutes and what it will mean to you |
Oxford Nanopore is a British company, spun out of the University of Oxford in 2005 and founded on the science of Prof Hagan Bayley. It is developing new technology that has the potential to improve greatly the speed and cost of DNA sequencing. |
Hagan Bayley |
25 Mar 2013 |
17 |
Creative Commons |
Diabetes and Genomics |
Professor Mark McCarthy tells us how genomics helps us understand diabetes. |
Mark McCarthy |
03 Jul 2012 |
18 |
Creative Commons |
Diabetes and Genomics |
Professor Mark McCarthy tells us how genomics helps us understand diabetes. |
Mark McCarthy |
03 Jul 2012 |
19 |
Creative Commons |
Procardis Study; Genome wide associations with Disease |
Paula Boddington gives a talk on the Procardis study as part of the Oxford Bioethics Network series on Issues in Research Ethics. |
Paula Boddington |
27 May 2010 |
20 |
Creative Commons |
Ethics and Genomic Research |
Paula Boddington gives a talk on ethical issues within genomics research as part of the Oxford Bioethics Network series on Issues in Research Ethics. |
Paula Boddington |
27 May 2010 |
21 |
|
Craig Venter on Genomics |
In the second of the Distinguished Public Lecture Series run by the James Martin 21st Century School, Dr Craig Venter discusses his work at the J. Craig Venter Institute and its implications for the future of our culture, society and science. |
J Craig Venter |
12 Sep 2008 |
22 |
|
Craig Venter on Genomics: From humans to the environment |
In the second of the Distinguished Public Lecture Series run by the James Martin 21st Century School, Dr Craig Venter will discuss his work at the J Craig Venter Institute and its implications for the future of our culture, society and science. |
J Craig Venter |
14 Apr 2008 |